Indonesian parliament approves $1.8 bln capital top-up for state firms in 2024



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Indonesian parliament approves $1.8 bln capital top-up for state firms in 2024</title></head><body>

Adds details for PLN in paragraph 9-10

By Bernadette Christina

JAKARTA, Oct 2 (Reuters) -The Indonesian parliament's financial committee on Monday approved a 28.2 trillion rupiah ($1.82 billion) capital injection for several state companies by 2024, including for debt-strapped construction firms.

The committee also approved a 36.8 trillion rupiah ($2.37 billion) capital injection for several state firms for this year, the committee said in a livestreamed meeting.

Construction firm Hutama Karya will receive the biggest chunk amounting to 28.9 trillion rupiah this year and 18.6 trillion next year.

Authorities have said Hutama Karya will be tasked with taking over some of the assets of troubled construction firm Waskita Karya WSKT.JK.

Another debt-laden construction company, Wijaya Karya WIKA.JK, will get 6 trillion rupiah next year.

However, the 2024 capital injection was below an original proposal of 22.5 trillion rupiah for Hutama Karya and 8 trillion rupiah for Wijaya Karya.

Waskita and Wijaya Karya, among Indonesia's biggest construction firms, have been renegotiating their debt with lenders. The companies are overleveraged having been assigned by the government to build massive infrastructure projects.

Trading in Waskita shares has been suspended since May after it failed to secure bondholder approval to defer a coupon payment.

The committee also struck down a 10 trillion rupiah cash injection to state utility Perusahaan Listrik Negara (PLN).

Finance Minister Sri Mulyani Indrawati said the government will review the urgency of such support for PLN after the decision.

Hutama, Waskita, Wijaya Karya and PLN did not immediately respond to a request for comment.

($1 = 15,520.0000 rupiah)



Reporting by Bernadette Christina Munthe; Editing by Kanupriya Kapoor and Tom Hogue

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.